A cost effectiveness analysis of repeat screening for syphilis in pregnancy as an alternative screening strategy in the UK
Modelling the choice of high-risk human papillomavirus (HR-HPV) assay in the English cervical screening programme
Point of care testing: Disruptive innovation – is the NHS ready for it yet?
